16700911000001102: Mirtazapine 45mg orodispersible tablets (Pfizer Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)
\UK product\Virtual medicinal product\Mirtazapine 45mg orodispersible tablets\Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)
\UK product\Virtual therapeutic moiety\Mirtazapine\Mirtazapine 45mg orodispersible tablets\Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing alpha adrenergic receptor antagonist\Product containing mirtazapine\Mirtazapine\Mirtazapine 45mg orodispersible tablets\Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing mirtazapine\Mirtazapine\Mirtazapine 45mg orodispersible tablets\Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzazepine\Product containing mirtazapine\Mirtazapine\Mirtazapine 45mg orodispersible tablets\Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing tetracyclic compound and acting as antidepressant agent (product)\Product containing mirtazapine\Mirtazapine\Mirtazapine 45mg orodispersible tablets\Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antidepressant agent (product)\Medicinal product containing tetracyclic compound and acting as antidepressant agent (product)\Product containing mirtazapine\Mirtazapine\Mirtazapine 45mg orodispersible tablets\Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)
\Medicinal product\Product containing autonomic agent\Product containing alpha adrenergic receptor antagonist\Product containing mirtazapine\Mirtazapine\Mirtazapine 45mg orodispersible tablets\Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Apr 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

58690801000001116 Mirtazapine 45mg orodispersible tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

58690901000001110 Mirtazapine 45mg orodispersible tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Is a	Mirtazapine 45mg orodispersible tablets	true	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Has active ingredient	Mirtazapine	true	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Has specific active ingredient	Mirtazapine	true	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Has dispensed dose form	Orodispersible tablet	false	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Has excipient	Aspartame	false	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Has dispensed dose form	Conventional release orodispersible tablet	true	Inferred relationship	Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Has manufactured dose form	Conventional release orodispersible tablet	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Mirtazapine 45mg orodispersible tablets (Pfizer Ltd) 30 tablet	Has AMP	True	Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
58690801000001116	Mirtazapine 45mg orodispersible tablets (Pfizer Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
58690901000001110	Mirtazapine 45mg orodispersible tablets (Pfizer Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module